Flashback to 2023!
There have been significant advancements in 2023, aligned with the models performed at Epistem. Our dedicated scientific team always reviews the latest standout publications...
There have been significant advancements in 2023, aligned with the models performed at Epistem. Our dedicated scientific team always reviews the latest standout publications...
Introduction In the ever-evolving field of biomedical research, the search for advanced models to study human physiology and disease has led to groundbreaking discoveries....
Epistem Limited, a UK-based pre-clinical and clinical research services company, has expanded its in vitro model portfolio through an agreement with Hubrecht Organoid Technology (HUB). The...